182 related articles for article (PubMed ID: 20967207)
1. Convergence of Rad6/Rad18 and Fanconi anemia tumor suppressor pathways upon DNA damage.
Park HK; Wang H; Zhang J; Datta S; Fei P
PLoS One; 2010 Oct; 5(10):e13313. PubMed ID: 20967207
[TBL] [Abstract][Full Text] [Related]
2. Advances in the understanding of the Fanconi anemia tumor suppressor pathway.
Pickering A; Zhang J; Panneerselvam J; Fei P
Cancer Biol Ther; 2013 Dec; 14(12):1089-91. PubMed ID: 24025411
[TBL] [Abstract][Full Text] [Related]
3. Rad18-mediated translesion synthesis of bulky DNA adducts is coupled to activation of the Fanconi anemia DNA repair pathway.
Song IY; Palle K; Gurkar A; Tateishi S; Kupfer GM; Vaziri C
J Biol Chem; 2010 Oct; 285(41):31525-36. PubMed ID: 20675655
[TBL] [Abstract][Full Text] [Related]
4. FANCD2 monoubiquitination provides a link between the HHR6 and FA-BRCA pathways.
Zhang J; Zhao D; Wang H; Lin CJ; Fei P
Cell Cycle; 2008 Feb; 7(3):407-13. PubMed ID: 18277096
[TBL] [Abstract][Full Text] [Related]
5. In vitro FANCD2 monoubiquitination by HHR6 and hRad18.
Pickering A; Panneerselvam J; Zhang J; Zheng J; Zhang Y; Fei P
Cell Cycle; 2013 Nov; 12(21):3448-9. PubMed ID: 24036990
[No Abstract] [Full Text] [Related]
6. Rad18 E3 ubiquitin ligase activity mediates Fanconi anemia pathway activation and cell survival following DNA Topoisomerase 1 inhibition.
Palle K; Vaziri C
Cell Cycle; 2011 May; 10(10):1625-38. PubMed ID: 21478670
[TBL] [Abstract][Full Text] [Related]
7. A novel role for non-ubiquitinated FANCD2 in response to hydroxyurea-induced DNA damage.
Chen X; Bosques L; Sung P; Kupfer GM
Oncogene; 2016 Jan; 35(1):22-34. PubMed ID: 25893307
[TBL] [Abstract][Full Text] [Related]
8. A ubiquitin-binding protein, FAAP20, links RNF8-mediated ubiquitination to the Fanconi anemia DNA repair network.
Yan Z; Guo R; Paramasivam M; Shen W; Ling C; Fox D; Wang Y; Oostra AB; Kuehl J; Lee DY; Takata M; Hoatlin ME; Schindler D; Joenje H; de Winter JP; Li L; Seidman MM; Wang W
Mol Cell; 2012 Jul; 47(1):61-75. PubMed ID: 22705371
[TBL] [Abstract][Full Text] [Related]
9. Coordination of the recruitment of the FANCD2 and PALB2 Fanconi anemia proteins by an ubiquitin signaling network.
Bick G; Zhang F; Meetei AR; Andreassen PR
Chromosoma; 2017 Jun; 126(3):417-430. PubMed ID: 27277787
[TBL] [Abstract][Full Text] [Related]
10. RAD18-mediated ubiquitination of PCNA activates the Fanconi anemia DNA repair network.
Geng L; Huntoon CJ; Karnitz LM
J Cell Biol; 2010 Oct; 191(2):249-57. PubMed ID: 20937699
[TBL] [Abstract][Full Text] [Related]
11. The identification of FANCD2 DNA binding domains reveals nuclear localization sequences.
Niraj J; Caron MC; Drapeau K; Bérubé S; Guitton-Sert L; Coulombe Y; Couturier AM; Masson JY
Nucleic Acids Res; 2017 Aug; 45(14):8341-8357. PubMed ID: 28666371
[TBL] [Abstract][Full Text] [Related]
12. Physical and functional crosstalk between Fanconi anemia core components and the GINS replication complex.
Tumini E; Plevani P; Muzi-Falconi M; Marini F
DNA Repair (Amst); 2011 Feb; 10(2):149-58. PubMed ID: 21109493
[TBL] [Abstract][Full Text] [Related]
13. Rad18 confers hematopoietic progenitor cell DNA damage tolerance independently of the Fanconi Anemia pathway in vivo.
Yang Y; Poe JC; Yang L; Fedoriw A; Desai S; Magnuson T; Li Z; Fedoriw Y; Araki K; Gao Y; Tateishi S; Sarantopoulos S; Vaziri C
Nucleic Acids Res; 2016 May; 44(9):4174-88. PubMed ID: 26883629
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of Ubiquitination and Deubiquitination in the Fanconi Anemia Pathway.
van Twest S; Murphy VJ; Hodson C; Tan W; Swuec P; O'Rourke JJ; Heierhorst J; Crismani W; Deans AJ
Mol Cell; 2017 Jan; 65(2):247-259. PubMed ID: 27986371
[TBL] [Abstract][Full Text] [Related]
15. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.
Siddique MA; Nakanishi K; Taniguchi T; Grompe M; D'Andrea AD
Exp Hematol; 2001 Dec; 29(12):1448-55. PubMed ID: 11750104
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
Adachi D; Oda T; Yagasaki H; Nakasato K; Taniguchi T; D'Andrea AD; Asano S; Yamashita T
Hum Mol Genet; 2002 Dec; 11(25):3125-34. PubMed ID: 12444097
[TBL] [Abstract][Full Text] [Related]
17. Genomic instability in mice is greater in Fanconi anemia caused by deficiency of Fancd2 than Fancg.
Reliene R; Yamamoto ML; Rao PN; Schiestl RH
Cancer Res; 2010 Dec; 70(23):9703-10. PubMed ID: 21118969
[TBL] [Abstract][Full Text] [Related]
18. Proteasome function is required for DNA damage response and fanconi anemia pathway activation.
Jacquemont C; Taniguchi T
Cancer Res; 2007 Aug; 67(15):7395-405. PubMed ID: 17671210
[TBL] [Abstract][Full Text] [Related]
19. The Fanconi anemia ID2 complex: dueling saxes at the crossroads.
Boisvert RA; Howlett NG
Cell Cycle; 2014; 13(19):2999-3015. PubMed ID: 25486561
[TBL] [Abstract][Full Text] [Related]
20. A novel role for Fanconi anemia (FA) pathway effector protein FANCD2 in cell cycle progression of untransformed primary human cells.
Song IY; Barkley LR; Day TA; Weiss RS; Vaziri C
Cell Cycle; 2010 Jun; 9(12):2375-88. PubMed ID: 20519958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
